Updates to U.S. close
World equity indexes down 0.1%
S&P, Dow Jones Industrial Average higher; Nasdaq slips
Fed meeting, tech earnings in focus
Palladium hits record high
Dollar steadies, up from multiweek lows
By Matt Scuffham and Danilo Masoni
NEW YORK/MILAN, April 27 (Reuters) - Shares eased from record peaks on Tuesday as optimism about a global economic recovery was dented by caution before a policy decision by the U.S. Federal Reserve and earnings updates from a number of blue-chip companies.
MSCI's gauge of stocks across the globe .MIWD00000PUS shed 0.11%.
The world index has risen 9% so far this year, underpinned by expectations that rising COVID-19 vaccination rates will allow more economies to recover and give a big boost to company profits.
Earnings in Europe are expected to have risen 61% in the first quarter, while U.S. profits are seen up more than 31%, according to the latest Refinitiv IBES estimates.
Many investors, however, stayed on the sidelines ahead of the Fed meeting which ends on Wednesday, when the U.S. central bank is expected to confirm that it will maintain its easy monetary policy to bolster the economy.
One area of concern was India, which is struggling with surging coronavirus infections that have overwhelmed its healthcare system.
Markets were also awaiting results from U.S. tech heavyweights Microsoft Corp MSFT.O and Alphabet Inc GOOGL.O later on Tuesday. Companies that represent about 40% of the S&P 500's market capitalization report from Tuesday through Thursday.
Some analysts say the recent rally has made stocks vulnerable to profit taking, given lofty valuations and high expectations going into the reporting season.
"We've been in a significant rally for quite some time," said Tim Ghriskey, chief investment strategist at Inverness Counsel in New York. "The laws of gravity tell you that at some point we're going to see a pullback."
Major U.S. indices were mixed.
The Dow Jones Industrial Average .DJI rose 3.36 points, or 0.01%, to 33,984.93, the S&P 500 .SPX lost 0.9 points, or 0.02%, to 4,186.72 and the Nasdaq Composite .IXIC dropped 48.56 points, or 0.34%, to 14,090.22.
In Europe, bank results got the attention. Strong earnings sent shares in Europe's biggest bank by assets, HSBC HSBA.L, up 4.2%, while UBS UBSG.S fell 2.0% after a surprise hit linked to the collapse of hedge fund Archegos.
The pan-European STOXX 600 index .STOXX slipped 0.1%.
Palladium prices hit a record, spurred by persistent supply worries, while gold held a narrow range as investors awaited policy signals from the Fed's meeting.
Palladium XPD= hit a record of $2,962.50 per ounce.
Spot gold XAU= dropped 0.3% to $1,775.57 an ounce.
U.S. gold futures GCv1 settled down 0.1% at $1,778.8 an ounce.
Oil rebounded as optimism ahead of a meeting of producer group OPEC+ to discuss output policy offset concern that India's coronavirus crisis could dent a recovery in fuel demand.
U.S. crude futures CLc1 settled at $62.94 per barrel, up $1.03 or 1.66%. Brent crude futures LCOc1 settled at $66.42 per barrel, up 77 cents or 1.17%.
The dollar hovered near multiweek lows versus other major currencies, but moves were narrow as traders avoided taking out big positions before a bond auction and the Fed meeting.
The dollar index =USD rose 0.024%.
"Nobody really believes that the Fed will change its forward guidance, but, just in case, investors appear to be loading up on U.S. dollar as a hedge," said OANDA analyst Jeffrey Halley.
Bond traders were closely watching an auction of $62 billion of seven-year U.S. Treasuries later on Tuesday.
Benchmark 10-year notes US10YT=RR last fell 16/32 in price to yield 1.627%, from 1.57% late on Monday.
Bitcoin BTC=BTSP rose 1% to $54,636. The world's most popular cryptocurrency soared nearly 10% on Monday, after five straight days of losses, on reports that JPMorgan Chase JPM.N is planning to offer a managed Bitcoin fund.
Bitcoin had slumped almost a fifth from an all-time high hit this month.
(Reporting by Matt Scuffham in New York and Danilo Masoni in Milan; Editing by Estelle Shirbon, Will Dunham, John Stonestreet and Jonathan Oatis)
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.